Monte Rosa Therapeutics, Inc. (GLUE)

16.53 -0.03 (-0.18%) USD  |  NASDAQ  |  Dec 12, 12:31
More

Monte Rosa Therapeutics EBITDA (Quarterly)

EBITDA (Quarterly) Chart

View EBITDA (Quarterly) for GLUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (Quarterly) Range, Past 5 Years

View EBITDA (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (Quarterly) Benchmarks

View EBITDA (Quarterly) Benchmarks
Start Trial
Novartis AG Upgrade
AVITA Medical, Inc. Upgrade
NanoVibronix, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Day One Biopharmaceuticals, Inc. Upgrade